U. S. Securities and Exchange Commission
                         Washington, D. C.  20549


                                FORM 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarterly period ended September 30, 2002

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from                to
                                    --------------    ---------------


                       Commission File No. 0-23511


                           FIRST DELTAVISION, INC.
                           -----------------------
              (Name of Small Business Issuer in its Charter)


           NEVADA                                       87-0412182
           ------                                       ----------
   (State or Other Jurisdiction of                (I.R.S. Employer I.D. No.)
    incorporation or organization)

                          9005 Cobble Canyon Lane
                            Sandy, Utah 84093
                        --------------------------
                 (Address of Principal Executive Offices)

                Issuer's Telephone Number:  (801) 942-0555

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.

(1)  Yes  X    No                  (2)  Yes  X   No
         ---     ---                        ---     ---

<PAGE>
             APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                PROCEEDINGS DURING THE PRECEDING FIVE YEARS

                              Not applicable.


                   APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the Registrant's
classes of common stock, as of the latest practicable date:

                            October 31, 2002

                                 1,342,000*
                                 ----------

          * See Item 5; all computations herein take into account a four for
one forward split effected by dividend on April 4, 2002.

                      PART I - FINANCIAL INFORMATION

Item 1.   Financial Statements.

          The Financial Statements of the Registrant required to be filed
with this 10-QSB Quarterly Report were prepared by management, and commence
on the following page, together with Related Notes.  In the opinion of
management, the Financial Statements fairly present the financial condition
of the Registrant.
<PAGE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

             UNAUDITED CONDENSED FINANCIAL STATEMENTS

                        SEPTEMBER 30, 2002
<PAGE>
                      FIRST DELTAVISION, INC.
                   [A Development Stage Company]




                             CONTENTS

                                                               PAGE

        Unaudited Condensed Balance Sheets, September 30,
             2002 and June 30, 2002                                   2

        Unaudited Condensed Statements of Operations,
             for the three months ended September 30, 2002
             and 2001 and from inception on July 31, 1984
             through September 30, 2002                               3

        Unaudited Condensed Statements of Cash Flows,
             for the three months ended September 30, 2002
             and 2001 and from inception on July 31, 1984,
             through September 30, 2002                               4

           Notes to Unaudited Condensed Financial Statements      5 - 9
<PAGE>
<TABLE>
<CAPTION>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

                UNAUDITED CONDENSED BALANCE SHEETS




                              ASSETS


                                            September 30,      June 30,
                                                  2002         2002
                                        ________________________________
<S>                                     <C>                <C>
CURRENT ASSETS                            $          -     $        -
                                        ________________________________
        Total Current Assets                         -              -
                                        ________________________________
                                          $          -     $        -
                                        ================================


          LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)


CURRENT LIABILITIES:
  Accounts payable                        $                  -   $ 1,230
  Accounts payable - related party                      39,317    39,317
  Due to officers                                       32,721    31,126
                                        ________________________________
        Total Current Liabilities                       72,038    71,673
                                        ________________________________

STOCKHOLDERS' EQUITY (DEFICIT):
  Common stock, $.001 par value,
   50,000,000 shares authorized,
   1,342,000 shares issued
   and outstanding                                       1,342     1,342
  Capital in excess of par value                       101,269   101,269
  Deficit accumulated during the
    development stage                                 (174,649) (174,284)
                                        ________________________________
        Total Stockholders' Equity (Deficit)           (72,038)  (71,673)
                                        ________________________________
                                          $                  - $       -
                                        ================================

</TABLE>

Note:  The Balance Sheet as of June 30, 2002, was taken from the audited
financial statements at that date and condensed.

The accompanying notes are an integral part of these unaudited condensed
financial statements.

                                2
<PAGE>
<TABLE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]
<CAPTION>

             UNAUDITED CONDENSED STATEMENTS OF OPERATIONS


                                        For the Three         From Inception
                                        Months Ended           on July 31,
                                        September 30,          1984 through
                                      ______________________  September 30,
                                      2002         2001           2002
                                      __________ ___________ _______________
<S>                                  <C>       <C>         <C>
REVENUE:
  Sales                               $        - $         - $             -
                                      __________ ___________ _______________

                 Total Revenue                 -           -               -
                                      __________ ___________ _______________
EXPENSES:
  General and
  administrative                             365       3,536         174,649
                                      __________ ___________ _______________

                 Total Expenses             (365)     (3,536)       (174,649)
                                      ---------- ----------- ---------------
LOSS FROM OPERATIONS
BEFORE INCOME TAXES                         (365)     (3,536)       (174,649)

CURRENT INCOME TAXES                           -           -               -

DEFERRED INCOME TAX                            -           -               -
                                      __________ ___________ _______________
NET LOSS                              $     (365)$    (3,536)$      (174,649)
                                      ---------- ----------- ---------------
LOSS PER SHARE:                       $     (.00)$      (.00)$          (.37)
                                      ========== =========== ===============
</TABLE>
The accompanying notes are an integral part of these unaudited condensed
financial statements.
                                3
<PAGE>
<TABLE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]
<CAPTION>
           UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

                                                              From Inception
                                         For the Three months    on July 31,
                                         Ended September 31,    1984 through
                                        ______________________  September 31,
<S>                                      <C>         <C>            <C>
                                         2002        2001           2002
                                        __________   __________  ____________
Cash Flows From Operating Activities:
  Net loss                              $     (365)  $   (3,536) $  (174,649)
Adjustments to reconcile net loss to
net cash used by operating activities:
 Non cash expense                                -            -       39,255
 Stock issued for relief of debt                 -            -        1,000
 Changes in assets and liabilities:
  (Decrease) in accounts payable            (1,230)        (235)           -
  Increase in accounts payable-related
   party                                         -        2,890       39,317
  Increase in due to officers                1,595          881       32,721
                                        __________   __________  ____________
      Net Cash (Used) by
        Operating Activities                     -            -      (62,356)
                                        __________   __________  ____________
Cash Flows From Investing Activities:            -            -             -
                                        __________   __________  ____________
      Net Cash (Used) by
        Investing Activities                     -            -             -
                                        __________   __________  ____________
Cash Flows From Financing Activities:
  Proceeds from issuance of common stock         -            -        58,776
  Capital contributions                          -            -         3,580
                                        __________   __________  ____________
        Net Cash Provided by
          Financing Activities                   -            -        62,356
                                        __________   __________  ____________
Net Increase in Cash                             -            -             -

Cash at Beginning of the Period                  -            -             -
                                        __________   __________  ____________
Cash at End of the Period               $        -   $        -  $          -
                                        ==========   ==========  ============

Supplemental Disclosures of Cash Flow Information:

  Cash paid during the period for:
    Interest                            $        -   $        -  $          -
    Income taxes                        $        -   $        -  $          -

Supplemental Schedule of Noncash Investing and Financing Activities:
  For the period ended September 30, 2002:
     None
  For the period ended September 30, 2001:
     None


The accompanying notes are an integral part of these unaudited condensed
financial statements.
</TABLE>
                                4
<PAGE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

        NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Organization - First Deltavision, Inc. ("the Company") was organized under the
laws of the State of Utah on July 31, 1984 under the name of Aquachlor
Marketing.  The Company never engaged in business activities and was suspended
for failure to file annual reports and tax returns.  In December 1988, all
required reports and tax returns were filed and the Company was reinstated by
the State of Utah.

On December 23, 1988, the Company merged with Aquachlor, Inc., a Nevada
Corporation, incorporated on December 20, 1988.  The Nevada Corporation became
the surviving corporation and changed its name to Deltavision, Inc.

On March 25, 1997, the Company received a Certificate of Revival from the
State of Nevada using the name First Deltavision, Inc.

The Company has not engaged in any business activities that have produced
significant revenues and therefore remains a development stage company as
defined in Statement of Financial Accounting Standards No. 7.

Condensed Financial Statements - The accompanying financial statements have
been prepared by the Company without audit.  In the opinion of management, all
adjustments (which include only normal recurring adjustments) necessary to
present fairly the financial position, results of operations and cash flows at
September 30, 2002 and 2001 and for the periods then ended have been made.

Certain information and footnote disclosures normally included in financial
statements prepared in accordance with generally accepted accounting
principles in the United States of America have been condensed or omitted.  It
is suggested that these condensed financial statements be read in conjunction
with the financial statements and notes thereto included in the Company's June
30, 2002 audited financial statements.  The results of operations for the
periods ended September 30, 2002 and 2001 are not necessarily indicative of
the operating results for the full year.

Cash and Cash Equivalents - The Company considers all highly liquid debt
investments purchased with a maturity of three months or less to be cash
equivalents.

Loss Per Share - The computation of loss per share of common stock is based on
the weighted average number of shares outstanding during the periods
presented, in accordance with Statement of Financial Accounting Standards No.
128, "Earnings Per Share" [See Note 7].

Accounting Estimates - The preparation of financial statements in conformity
with generally accepted accounting principles in the United States of America
required management to make estimates and assumptions that effect the reported
amounts of assets and liabilities, the disclosures of contingent assets and
liabilities at the date of the financial statements, and the reported amounts
of revenues and expenses during the reporting period.  Actual results could
differ from those estimated by management.
                                5
<PAGE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

                  NOTES TO FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Continued]

Recently Enacted Accounting Standards - Statement of Financial Accounting
Standards ("SFAS") No. 141, "Business Combinations", SFAS No. 142, "Goodwill
and Other Intangible Assets", SFAS No. 143, "Accounting for Asset Retirement
Obligations", SFAS No. 144, "Accounting for the Impairment or Disposal of
Long-Lived Assets", SFAS No. 145, "Rescission of FASB Statements No. 4, 44,
and 64, Amendment of FASB Statement No. 13, and Technical Corrections", SFAS
No. 146, "Accounting for Costs Associated with Exit or Disposal Activities",
and SFAS No. 147, "Acquisitions of Certain Financial Institutions - an
Amendment of FASB Statements No. 72 and 144 and FASB Interpretation No. 9",
were recently issued.  SFAS No. 141, 142, 143, 144, 145, 146 and 147 have no
current applicability to the Company or their effect on the financial
statements would not have been significant.

Restatement - The financial statements have been restated for all periods
presented to reflect a 4 for 1 forward stock split on April 4, 2002, a 248.399
for 1 reverse stock split on April 23, 1997 and a 5 for 1 forward stock split
on December 9, 1988.

Reclassification - The financial statements for periods prior to September 30,
2002 have been reclassified to conform to the headings and classifications
used in the September 30, 2002 financial statements.

NOTE 2 - ACQUISITION/RESCISSION OF ACQUISITION

On April 9, 2002, the Company entered into a share exchange agreement with
KyoMedix Corporation ("KyoMedix").  The agreement called for the Company to
issue 15,166,550 shares of common stock to the shareholders of KyoMedix for
all of the issued and outstanding shares of common stock of KyoMedix.  The
agreement also called for the repurchase and cancellation of 746,592 shares of
common stock for a $250,000 note payable and effecting a 4-for-1 forward stock
split.  The $250,000 note payable was due 90 days from signing and was secured
by 13,916,000 shares of common stock of the Company.  Any unpaid portion of
the note was to accrue interest at 10% per annum after the 90-day term.  The
agreement also called for the resignation of the Company's officers and
directors, the adoption of the 2002 Stock Plan of KyoMedix, changing the name
of the Company to KyoMedix, Inc. and the grant of similar options to replace
the options previously granted by KyoMedix.  The acquisition closed April 9,
2002; however, subsequently, former and current shareholders of the Company
sued to rescind the merger claiming that certain conditions of the agreement
were not satisfied.  On November 11, 2002, the Company signed a Compromise and
Settlement Agreement and the Company cancelled the 15,166,550 shares of common
stock that had been issued to the shareholders of KyoMedix.  As part of the
rescission agreement, the Company reissued 746,592 shares of common stock to
the previous shareholder and the $250,000 note payable was voided.  As part of
the rescission agreement, the Company's former officers and directors were re-
appointed, the adoption of the 2002 Stock Plan of KyoMedix was voided and
options granted to KyoMedix option holders were cancelled.  The financial
statements have been restated to reflect the acquisition as having been
rescinded.
                                6
<PAGE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

                  NOTES TO FINANCIAL STATEMENTS

NOTE 3 - COMMON STOCK

The Company issued 91,452 shares of stock upon incorporation for $57,576.

During the year ended June 30, 1989 the Company issued 96,640 shares of common
stock for $1,200.

During 1996, the Company issued 611,908 shares of common stock for consulting
fees valued at $38,000 (or $.25 per share) resulting in a change in control of
the Company.

During the year ended June 30, 1998, the Company issued 142,000 shares of
common stock for services rendered.  Total proceeds amounted to $1,255 (or
$.04 per share).  The Company previously reported the issuance as 140,000
shares of common stock.  The financial statements have been restated for the
years ended June 30, 1999 and 1998 to reflect the issuance of an additional
2,000 shares of common stock related to services previously rendered.

In January 2000, the board of directors approved a compensation agreement that
included the issuance of a total of 400,000 shares of common stock to two
shareholders, 200,000 to each, for services rendered which were valued at
$1,000.  The shares were issued in August 2000 for $.0025 per share.

Stock Splits - On December 9, 1988, the Company effected a 5 for 1 forward
stock split.  On April 23, 1997, the Company effected a 248.399 for 1 reverse
stock split.  On April 4, 2002, the Company effected a 4 for 1 forward stock
split.  The financial statements for all periods presented have been restated
to reflect these stock splits.

NOTE 4 - INCOME TAXES

The Company accounts for income taxes in accordance with Statement of
Financial Accounting Standards No. 109 "Accounting for Income Taxes" which
requires the liability approach for the effect of income taxes.

The Company has available at September 30, 2002, unused operating loss
carryforwards of approximately $73,300, which may be applied against future
taxable income and which expire in various years through 2023.  If certain
substantial changes in the Company's ownership should occur, there could be an
annual limitation on the amount of net operating loss carryforward, which can
be utilized.  The amount of and ultimate realization of the benefits from the
operating loss carryforwards for income tax purposes is dependent, in part,
upon the tax laws in effect, the future earnings of the Company and other
future events, the effects of which cannot be determined.  Because of the
uncertainty surrounding the realization of the loss carryforwards, the Company
has established a valuation allowance equal to the tax effect of the loss
carryforwards, therefore, no deferred tax asset has been recognized for the
loss carryforwards.  The net deferred tax assets are approximately $24,900 and
$24,800 at September 30, 2002 and June 30, 2002, respectively, resulting in a
change in the valuation allowance of approximately $100 during the three
months ended September 30, 2002.
                                7
<PAGE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

                  NOTES TO FINANCIAL STATEMENTS

NOTE 5 - RELATED PARTY TRANSACTIONS

Management Compensation - During the three months ended September 30, 2002 and
2001, the Company did not pay any compensation to its officers and directors.

Office Space - The Company has not had a need to rent office space.  An
officer/shareholder of the Company is allowing the Company to use his home as
a mailing address, as needed, at no expense to the Company.

Due to Officers - The Company's president has paid expenses on behalf of the
Company in the amount of $1,595 during the three months ended September 30,
2002.  At September 30, 2002, the total amount owed to the Company's president
was $32,721.  This amount bears no interest and is due when the funds are
available.

Accounts Payable - A shareholder of the Company provides legal services to the
Company.  At September 30, 2002, the value of the services rendered but unpaid
is $39,317.  This amount bears no interest and is due when the funds are
available.

NOTE 6 - GOING CONCERN

The accompanying financial statements have been prepared in conformity with
generally accepted accounting principles in the United States of America,
which contemplate continuation of the Company as a going concern.  However,
the Company has incurred losses since its inception, has current liabilities
in excess of current assets and has not yet been successful in establishing
profitable operations.  These factors raise substantial doubt about the
ability of the Company to continue as a going concern.  In this regard,
management is proposing to raise any necessary additional funds not provided
by operations through loans or through sales of its common stock or through a
possible business combination with another company.  There is no assurance
that the Company will be successful in raising this additional capital or
achieving profitable operations.  The financial statements do not include any
adjustments that might result from the outcome of these uncertainties.
                                8
<PAGE>
                     FIRST DELTAVISION, INC.
                  [A Development Stage Company]

                  NOTES TO FINANCIAL STATEMENTS

NOTE 7 - LOSS PER SHARE

The following data show the amounts used in computing loss per share for the
periods presented:

                               For the Three    From Inception
                                Months Ended   on July 31, 1984,
                               September 30,       through
                              _______________    September 30,
                               2002     2001         2002
                              _______________   ______________
    Loss from continuing
      operations available to
      common stockholders
       (numerator)            $  (365)$(3,536)  $    (174,649)
                              _______ _______   ______________
    Weighted average number of
      common shares outstanding
      used in earnings per share
      during the period
      (denominator)        1,342,000 1,342,000        476,044
                           _________ _________   ______________


Dilutive loss per share was not presented, as the Company had no common
equivalent shares for all periods presented that would effect the computation
of diluted loss per share.

NOTE 8 - SUBSEQUENT EVENT

On November 11, 2002, the Company signed a Compromise and Settlement Agreement
and the Company cancelled the 15,166,550 shares of common stock that had been
issued to the shareholders of KyoMedix [See Note 2].  As part of the
rescission agreement, the Company reissued 746,592 shares of common stock to
the previous shareholder and the $250,000 note payable was voided.  As part of
the rescission agreement, the Company's former officers and directors were re-
appointed, the adoption of the 2002 Stock Plan of KyoMedix was voided and
options granted to KyoMedix option holders were cancelled.  The financial
statements have been restated to reflect the acquisition as having been
rescinded.
                                9

<PAGE>

Item 2.   Management's Discussion and Analysis or Plan of Operation.
--------------------------------------------------------------------

Plan of Operation.
------------------

         We are presently attempting to determine which industries or areas
where we should concentrate our business efforts, and at that determination,
will formulate our business plan and commence operations.

         During the next 12 months, our only foreseeable cash requirements
will relate to maintaining our Company in good standing or the payment of
expenses associated with reviewing or investigating any potential
business venture.  Our Company may be required to sell shares of our
common stock to "accredited" or "sophisticated" investors or borrow from
members of management, as we have done in the past for the payment of expenses
related to these matters.

Results of Operations.
----------------------

          During the quarterly period ended September 30, 2002, we had no
business operations.  During this period, we received total revenues of $0 and
had a net loss of $(365).  There were also no revenues during the same quarter
of 2001.

Liquidity.
----------

          At September 30, 2002, we had no current assets, with total current
liabilities of $72,038.  Total stockholder's equity was $(72,038).  In order
to meet its expenses during the next 12 months, management expects that we may
be required to sell shares of our common stock to "accredited" or
"sophisticated" investors or borrow from members of our management, as we have
done in the past, to pay required expenses.

Item 3.   Controls and Procedures.
----------------------------------

         (a)  Evaluation of Disclosure Controls and Procedures

         Our President and Secretary/Treasurer have evaluated our Company's
disclosure controls and procedures as of November 14, 2002, and
they concluded that these controls and procedures are effective.

         (b)  Changes in Internal Controls

         There are no significant changes in internal controls or in other
factors that could significantly affect these controls subsequent to November
14, 2002.

                        PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.
----------------------------

          None; not applicable.

Item 2.   Changes in Securities.
--------------------------------

          See Item 5.

Item 3.   Defaults Upon Senior Securities.
------------------------------------------

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.
--------------------------------------------------------------

          None; not applicable.

Item 5.   Other Information.
----------------------------

          On April 9, 2002, following a four for one forward split, effected
by dividend, of our outstanding securities, we; KyoMedix Corporation, a
Delaware corporation ("KyoMedix"), and Atlantic Capital Partners Inc. and
Health Sciences International Inc., shareholders of KyoMedix (the "KyoMedix
Stockholders"), executed a Share Exchange Agreement (the "Kyomedix Agreement")
whereby 100% of the issued and outstanding shares of common stock of KyoMedix
were converted into and exchanged for 15,166,550 of our post-dividend shares
of common stock or approximately 96% of our post-Kyomedix Agreement
outstanding securities, taking into account the cancellation pursuant to the
Kyomedix Agreement of 186,648 pre-dividend shares of our common stock that
were owned by David C. Merrell, our President and one of our directors.  For
additional information regarding the Kyomedix Agreement, see our 8-K Current
Report dated April 9, 2002, which was filed with the Securities and Exchange
Commission on April 25, 2002, and which is incorporated herein by reference.
See Item 6.

          Effective November 11, 2002, following the filing of legal
proceedings by Mr. Merrell and pursuant to a Compromise and Settlement
Agreement, the Kyomedix Agreement was rescinded by the parties and declared
null and void; all shares issued and exchanged by us thereunder were canceled;
and the parties were placed in substantially the same positions that they were
respectively in immediately prior to the closing, with the exception that we
retained the four for one forward split of our outstanding securities.
Following the cancellation of all shares issued under the Kyomedix Agreement
and the re-issuance of the 186,648 pre-dividend shares canceled by Mr. Merrell
(amounting to 746,592 shares with the dividend), our outstanding securities
amounted to 1,342,000 shares.  For additional information regarding this
Compromise and Settlement Agreement, see our 8-K Current Report dated April 9,
2002, which was filed with the Securities and Exchange Commission on
November 13, 2002, and which is incorporated herein by reference.

Item 6.   Exhibits and Reports on Form 8-K.
-------------------------------------------

          (a)  Exhibits.

               None.

          (b)  Reports on Form 8-K.

               Form 8-K Current Report dated April 9, 2002*

               Form 8-KA Current Report dated April 9, 2002*

             *Incorporated herein by reference.
<PAGE>

                               SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its behalf
by the undersigned thereunto duly authorized.

                                      FIRST DELTAVISION, INC.



Date: 11/14/02                        By/S/David C. Merrell
     --------------                   -------------------------------------
                                        David C. Merrell
                                        Director and President


Date: 11/14/02                        By/S/Todd D. Ross
     --------------                   -------------------------------------
                                        Todd D. Ross
                                        Director and Treasurer
<PAGE>

                   CERTIFICATION PURSUANT TO
         SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, David C. Merrell, President of First Deltavision, Inc. (the
"Registrant"), certify that:

     1.   I have reviewed this Quarterly Report on Form 10-KSB of the
Registrant;

     2.   Based on my knowledge, this Quarterly Report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this Quarterly Report;

     3.   Based on my knowledge, the financial statements, and other
financial information included in this Quarterly Report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the Registrant as of, and for, the periods presented in this
Quarterly Report;

     4.   The Registrant's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and we
have:

     a)   designed such disclosure controls and procedures to ensure that
          material information relating to the Registrant, including its
          consolidated subsidiaries, is made known to us by others within
          those entities, particularly during the period in which this
          Quarterly Report is being prepared;

     b)   evaluated the effectiveness of the Registrant's disclosure
          controls and procedures as of a date within 90 days prior to the
          filing date of this Quarterly Report (the "Evaluation Date"); and

     c)   presented in this Quarterly Report our conclusions about the
          effectiveness of the disclosure controls and procedures based on
          our evaluation as of the Evaluation Date;

     5.   The Registrant's other certifying officer and I have disclosed,
based on our most recent evaluation, to the Registrant's auditors and the
audit committee of Registrant's board of directors (or persons performing the
equivalent function);

     a)   all significant deficiencies in the design or operation of
          internal controls which could adversely affect the Registrant's
          ability to record, process, summarize and report financial data
          and have identified for the Registrant's auditors any material
          weaknesses in internal controls; and

     b)   any fraud, whether or not material, that involves management or
          other employees who have a significant role in the Registrant's
          internal controls; and

     6.   The Registrant's other certifying officer and I have indicated in
this Quarterly Report whether or not there were significant changes in
internal controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation, including any
corrective actions with regard to significant deficiencies and material
weaknesses.

Dated:  November 14, 2002            Signature:/s/David C. Merrell
                                     David C. Merrell
                                     President
<PAGE>
                   CERTIFICATION PURSUANT TO
         SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, Todd D. Ross, Secretary/Treasurer of First Deltavision, Inc. (the
"Registrant"), certify that:

     1.   I have reviewed this Quarterly Report on Form 10-KSB of the
Registrant;

     2.   Based on my knowledge, this Quarterly Report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this Quarterly Report;

     3.   Based on my knowledge, the financial statements, and other
financial information included in this Quarterly Report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the Registrant as of, and for, the periods presented in this
Quarterly Report;

     4.   The Registrant's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the Registrant and we
have:

     a)   designed such disclosure controls and procedures to ensure that
          material information relating to the Registrant, including its
          consolidated subsidiaries, is made known to us by others within
          those entities, particularly during the period in which this
          Quarterly Report is being prepared;

     b)   evaluated the effectiveness of the Registrant's disclosure
          controls and procedures as of a date within 90 days prior to the
          filing date of this Quarterly Report (the "Evaluation Date"); and

     c)   presented in this Quarterly Report our conclusions about the
          effectiveness of the disclosure controls and procedures based on
          our evaluation as of the Evaluation Date;

     5.   The Registrant's other certifying officer and I have disclosed,
based on our most recent evaluation, to the Registrant's auditors and the
audit committee of Registrant's board of directors (or persons performing the
equivalent function);

     a)   all significant deficiencies in the design or operation of
          internal controls which could adversely affect the Registrant's
          ability to record, process, summarize and report financial data
          and have identified for the Registrant's auditors any material
          weaknesses in internal controls; and

     b)   any fraud, whether or not material, that involves management or
          other employees who have a significant role in the Registrant's
          internal controls; and

     6.   The Registrant's other certifying officer and I have indicated in
this Quarterly Report whether or not there were significant changes in
internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Dated:  November 14, 2002            Signature:/s/Todd D. Ross
                                     Todd D. Ross
                                     Secretary/Treasurer

<PAGE>

                    CERTIFICATION PURSUANT TO
                     18 U.S.C. SECTION 1350,
                      AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of First Deltavision, Inc. (the
"Registrant") on Form 10-KSB for the fiscal year ended June 30, 2002, as filed
with the Securities and Exchange Commission on the date hereof, we,
David C. Merrell, President and Chief Executive Officer, and Todd D. Ross,
Secretary/Treasurer of the Registrant, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that, to the best of our knowledge and belief:

     (1) The Quarterly Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Quarterly Report fairly presents,
in all material respects, the financial condition and result of operations of
the Registrant.

Dated:  November 14, 2002            Signature:/s/David C. Merrell
                                     David C. Merrell
                                     President

Dated:  November 14, 2002            Signature:/s/Todd D. Ross
                                     Todd D. Ross
                                     Secretary/Treasurer